These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9884515)

  • 1. Seroepidemiological study on prevalence of measles antibodies in Urawa City.
    Tsuji A; Tanioku Y; Nakayama T
    Keio J Med; 1998 Dec; 47(4):209-11. PubMed ID: 9884515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998.
    Loo MK; Sabahi F; Soleimanjdahi H; Kazemnejad A; Roustai MH
    Eur J Epidemiol; 2003; 18(11):1085-9. PubMed ID: 14620944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to measles in the Croatian population.
    Borcić B; Mazuran R; Kaić B
    Eur J Epidemiol; 2003; 18(11):1079-83. PubMed ID: 14620943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sero-epidemiology of measles in children from Eastern Turkey.
    Altinkaynak S; Ertekin V; Güraksin A; Kiliç A; Yiğit N
    West Indian Med J; 2005 Sep; 54(4):236-7. PubMed ID: 16312189
    [No Abstract]   [Full Text] [Related]  

  • 5. Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil.
    Oliveira SA; Siqueira MM; Mann GF; Costa AJ; Almeida MT; Stavola MS; Tomasini H; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 1996; 38(5):355-8. PubMed ID: 9293077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies.
    Cutts FT; Bartoloni A; Guglielmetti P; Gil F; Brown D; Bianchi Bandinelli ML; Roselli M
    Trans R Soc Trop Med Hyg; 1995; 89(1):119-22. PubMed ID: 7747295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
    Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
    Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
    Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
    Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
    Saika S; Matsunaga T; Ogawa T; Ichinohe S
    Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gelatin particle agglutination and hemagglutination inhibition tests for measles seroepidemiology studies.
    Miyamura K; Sato TA; Sakae K; Kato N; Ogino T; Yashima T; Sasagawa A; Chikahira M; Itagaki A; Katsuki K; Matsunaga Y; Utagawa E; Takeda N; Inouye S; Yamazaki S
    Arch Virol; 1997; 142(10):1963-70. PubMed ID: 9413505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria.
    Onoja AB; Adeniji AJ
    Int J Infect Dis; 2013 Jul; 17(7):e552-5. PubMed ID: 23510540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroepidemiologic study of measles in 2 populations of children under 10 years of age from the metropolitan area].
    Ramírez E; Espiñeira E
    Rev Med Chil; 1992 May; 120(5):589-92. PubMed ID: 1343074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of measles in Japan: molecular and seroepidemiological studies.
    Okafuji T; Okafuji T; Fujino M; Nakayama T
    J Infect Chemother; 2006 Dec; 12(6):343-8. PubMed ID: 17235638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
    Ogundiji OT; Okonko IO; Adu FD
    J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.